BALLARINI, ELISA
 Distribuzione geografica
Continente #
NA - Nord America 5.904
EU - Europa 4.253
AS - Asia 1.989
SA - Sud America 25
OC - Oceania 23
AF - Africa 20
Continente sconosciuto - Info sul continente non disponibili 10
Totale 12.224
Nazione #
US - Stati Uniti d'America 5.803
IT - Italia 1.154
DE - Germania 1.004
SG - Singapore 768
CN - Cina 662
SE - Svezia 512
IE - Irlanda 404
RU - Federazione Russa 368
GB - Regno Unito 201
UA - Ucraina 190
HK - Hong Kong 139
AT - Austria 106
VN - Vietnam 103
CA - Canada 100
FI - Finlandia 77
DK - Danimarca 74
ID - Indonesia 73
JP - Giappone 58
IN - India 52
KR - Corea 51
FR - Francia 50
BE - Belgio 36
TR - Turchia 35
BR - Brasile 22
AU - Australia 20
PL - Polonia 18
NL - Olanda 14
IR - Iran 12
EG - Egitto 10
ES - Italia 10
EU - Europa 10
MY - Malesia 10
TW - Taiwan 9
RO - Romania 8
BG - Bulgaria 7
CH - Svizzera 5
CZ - Repubblica Ceca 5
TN - Tunisia 5
KW - Kuwait 4
SA - Arabia Saudita 4
LT - Lituania 3
NZ - Nuova Zelanda 3
SY - Repubblica araba siriana 3
AE - Emirati Arabi Uniti 2
IQ - Iraq 2
NG - Nigeria 2
PT - Portogallo 2
RS - Serbia 2
SC - Seychelles 2
AR - Argentina 1
BD - Bangladesh 1
CO - Colombia 1
EC - Ecuador 1
EE - Estonia 1
HR - Croazia 1
MX - Messico 1
NO - Norvegia 1
PH - Filippine 1
ZA - Sudafrica 1
Totale 12.224
Città #
Ann Arbor 1.945
Frankfurt am Main 770
Singapore 631
Milan 462
Chandler 406
Dublin 391
Wilmington 335
Dearborn 259
Woodbridge 248
Ashburn 228
Fairfield 192
Jacksonville 187
Houston 179
New York 171
Princeton 149
Santa Clara 148
Hong Kong 134
Boardman 106
Vienna 101
Nanjing 97
Shanghai 94
Seattle 81
Jakarta 73
Beijing 64
Guangzhou 63
Dong Ket 51
Saint Petersburg 38
Cambridge 37
Altamura 36
Chicago 33
Helsinki 33
Lawrence 32
Rome 32
Carate Brianza 30
Lachine 30
Shenyang 29
Brussels 27
Daejeon 27
Nanchang 27
Falls Church 26
Fremont 26
Ottawa 26
Pune 26
Andover 25
Toronto 23
Sacramento 21
Kunming 20
Jinan 19
Shangdi 19
London 17
Los Angeles 17
Florence 16
Melzo 16
Tianjin 16
Hangzhou 15
Nürnberg 15
Romola 15
Dallas 14
Kocaeli 14
San Diego 13
Sesto San Giovanni 13
Washington 13
Zhengzhou 13
Edmonton 12
Jiaxing 12
Shinjuku 12
Tokyo 12
Changsha 11
Hefei 11
Genoa 10
Hebei 10
Kiev 10
Kraków 10
Lappeenranta 10
Bergamo 9
Bolgare 9
Cagliari 9
Munich 9
Bologna 8
Changchun 8
Grafing 8
Mountain View 8
Ningbo 8
Bari 7
Canazei 7
Mainz 7
Norwalk 7
Piemonte 7
Seoul 7
Wuhan 7
Boston 6
Codroipo 6
Fuzhou 6
Guidonia 6
Leawood 6
Melbourne 6
Monza 6
Phoenix 6
Segrate 6
Shenzhen 6
Totale 8.719
Nome #
In vivo comparative study on acute and sub-acute biological e_ects induced by ultrafine particles of different anthropogenic sources in balb/c mice 384
ApoE-modified solid lipid nanoparticles: A feasible strategy to cross the blood-brain barrier 383
Design and Synthesis of Chitosan—Gelatin Hybrid Hydrogels for 3D Printable in vitro Models 332
Peripheral neuropathy induced by microtubule-targeted chemotherapies: Insights into acute injury and long-term recovery 321
miRNAs Affect the Expression of Innate and Adaptive Immunity Proteins in Celiac Disease 320
Therapeutic potential of Mesenchymal Stem Cells for the treatment of diabetic peripheral neuropathy 305
High-dose intravenous immunoglobulins reduce nerve macrophage infiltration and the severity of bortezomib-induced peripheral neurotoxicity in rats 300
Susceptibility of different mouse strains to oxaliplatin peripheral neurotoxicity: Phenotypic and genotypic insights 284
Systemic exposure to air pollution induces oxidative stress and inflammation in mouse brain, contributing to neurodegeneration onset 283
Gliadin, through the Activation of Innate Immunity, Triggers lncRNA NEAT1 Expression in Celiac Disease Duodenal Mucosa 239
Role of Organic Transporters 1 and 2 in Cisplatin mediated neurotoxicity 236
Age and Sex Influence the Neuro-inflammatory Response to a Peripheral Acute LPS Challenge 217
miR-192-5p and CXCL2/NOD2 inverse correlation in celiac disease 214
Topiramate prevents oxaliplatin-related axonal hyperexcitability and oxaliplatin induced peripheral neurotoxicity 209
Neuronopathies and polyneuropathies: a ready to use translational neurophysiological protocol in rodent models 200
Human Intravenous Immunoglobulin Alleviates Neuropathic Symptoms in a Rat Model of Paclitaxel-Induced Peripheral Neurotoxicity 199
The validation of neuroactive drug selection based on combinatorial screening in bortezomib-induced neurotoxicity models. 197
Neutrophil depletion affects Dark Agouti Experimental Autoimmune Encephalomyelitis 192
Oxaliplatin-induced neuropathy occurs through impairment of haemoglobin proton buffering and is reversed by carbonic anhydrase inhibitors 186
Effects of Islet Transplantation and Mesenchymal Stem Cell Co-Transplantation in the Protection of Diabetic Neuropathy in Streptozotocin-Induced Diabetic Rats 185
Assessment of oxaliplatin-induced peripheral neurotoxicity with different treatment schedules 178
Therapeutic Administration of Mesenchymal Stem Cells Abrogates the Relapse Phase in Chronic Relapsing-Remitting EAE 176
Oxidative stress and inflammation induced by acute and subacute ultrafine exposure: contrinbution to alzheimer's disease 173
In vitro morphological study of bortezomib-induced peripheral neurotoxicity 172
Paclitaxel: Chemotherapy and Neurotoxicity – The Two sides of the Coin 163
Multiple Sclerosis Drug Therapy: from the Classical Pharmaceutical down to Cellular and Molecular Approach 160
Effects induced by particles derived from two anthropogenic sources on respiratory, cardiovascular and central nervous systems 159
Caratterizzazione di un modello di encefalomielite autoimmune sperimentale e ruolo neuroprotettivo del progesterone 157
Neuroprotective effects of progesterone in chronic experimental autoimmune encephalomyelitis 156
Multiple Neuroprotective Mechanisms of Mesenchymal Stem Cells 151
Multimodal Analysis in Acute and Chronic Experimental Autoimmune Encephalomyelitis 141
Bortezomib-induced peripheral neurotoxicity in human multiple myeloma-bearing mice 139
Intravenous Immunoglobulin Preparation Attenuates Pain Behaviors in a Wistar Rat Model of Bortezomib-Induced Peripheral Neuropathy 139
Topiramate Prevents Oxaliplatin Neurotoxicity in a rat model 137
Preventive treatment with anti-rat neutrophil serum affects the relapsing phase in Dark Agouti EAE rats 136
Effectiveness of MSC therapeutic administration on rats affected by chronic Experimental Autoimmune Encephalomyelitis 135
Morphology meets function to unravel Oxaliplatin Induced Peripheral Neurotoxicity (OIPN) 135
Positive effect of Mesenchymal Stem Cells therapeutic administration on chronic Experimental Autoimmune Encephalomyelitis 131
Establishing sample-preparation protocols for X-ray phase-contrast CT of rodent spinal cords: Aldehyde fixations and osmium impregnation 131
MSCs effect on Dark Agouti rats affected by chronic EAE 129
Neutrophil depletion during sensitization phase affects the chronic phase of Experimental Autoimmune Encephalomyelitis 129
ERIBULIN, PACLITAXEL, IXABEPILONE AND VINORELBINE-INDUCED PERIPHERAL NEUROPATHY IN MICE: INSIGHTS IN LONG-TERM RECOVERY 128
Ivig Effect In A Wistar Rat Model Of Bortezomib-Induced Peripheral Neuropathy 128
Tackling Oxaliplatin Induced Peripheral neurotoxicity: from bed to bench side and back. 127
Morpho-Functional Characterisation of the Rat Ventral Caudal Nerve in a Model of Axonal Peripheral Neuropathy 126
ERK1 and ERK2 are involved in recruitment and maturation of human mesenchymal stem cells induced to adipogenic differentation 126
Human Immunoglobulins ameliorate pain in rats with bortezomib-induced peripheral neuropathy 125
Topiramate in Oxaliplatin-Induced Peripheral Neurotoxicity: more than neuroprotection. 125
Therapeutic potential of Mesenchymal Stem Cells for the treatment of type-1 Diabetes. 122
Co-trasplantation of Pancreatic Islets with Mesenchymal Stem Cells promotes the functional recovery of diabetic neuropathy in vivo 122
Oxaliplatin Neurotoxicity is related to SLC4A1 Expression in BALB/c Mice Dorsal Root Ganglia 121
Morphometrical characterization of DRG alterations induced by cisplatin and bortezomib in several mice models 120
Blood neurofilament light chains as a potential damage marker in chemotherapy-induce peripheral neuropathy rodent models 118
Oxaliplatin-Induced Peripheral Neurotoxicity: Morphological Characterization In Different Mouse Strains 117
Nose-to-brain delivery of polymeric nanoparticles 116
Macrophage infiltration in different preclinical models of chemotherapy-induced peripheral neurotoxicity 112
ERK1 and ERK2 involvement in human Mesenchymal Stem Cells adipogenic differentiation 110
Sodium-Calcium Exchanger 2: A Pivotal Role in Oxaliplatin Induced Peripheral Neurotoxicity and Axonal Damage? 105
Systems Pharmacology Modeling Identifies a Novel Treatment Strategy for Bortezomib-Induced Neuropathic Pain 102
Neutrophil contribution and immunoglobulin effect in Dark Agouti Experimental Autoimmune Encephalomyelitis. 102
Paclitaxel, but Not Cisplatin, Affects Satellite Glial Cells in Dorsal Root Ganglia of Rats with Chemotherapy-Induced Peripheral Neurotoxicity 101
Changes in neuroactive steroids in experimental autoimmune encephalomyelitis 101
Morphological and functional study of the caudal nerve in a rat model of peripheral neuropathy 97
Studying the caudal nerve anatomy and physiology to refine detection of peripheral nerve damage in rodent models. 96
Oxaliplatin induced peripheral neurotoxicity (OIPN) and ion unbalance: the perilous link between acute and chronic neurotoxicity. 94
Paclitaxel alters angiogenesis in the peripheral and central nervous system of neuropathic rats 94
Morphofunctional characterisation of axonal damage in different rat models of chemotherapy-induced peripheral neurotoxicity: the role of nerve excitability testing 93
Morphological and functional assessment of NCX2 potential role in axonal damage related to Oxaliplatin 93
Central and peripheral neoangiogenesis in paclitaxel-induced painful peripheral neuropathy 91
null 91
Effects of bortezomib-induced peripheral neuropathy on HSP27, HSP60 and HSP90 levels in the sciatic nerve 87
Oxaliplatin induced peripheral neurotoxicity (OIPN): a translational approach for drug discovery. 81
null 80
USING A 3D APPROACH TO DESCRIBE CELL POPULATIONS IN THE RAT DORSAL ROOT GANGLIA 80
Engineered mesoporous silica-based nanoparticles as smart chemotherapy nanodevice for bortezomib administration 79
NCX2 modulation to prevent axonal damage related to Oxaliplatin-induced peripheral neurotoxicity 76
New mechanisms of neurotoxicity related to oxaliplatin chemotherapy in mice 75
INVESTIGATING THE INVOLVEMENT OF SATELLITE GLIAL CELLS IN PACLITAXEL-INDUCED PERIPHERAL NEUROTOXICITY 75
Angiogenesis-Related New Mechanisms for Chemotherapy-Induced Painful Peripheral Neuropathy in the Rat 72
CHARACTERIZATION OF NEW MURINE MODELS OF PERIPHERAL NEUROPATHY INDUCED BY CHRONIC ADMINISTRATION OF ANTINEOPLASTIC COMPOUNDS 66
Oxaliplatin-induced peripheral neurotoxicity: molecular insights 65
Sodium/calcium exchanger (NCX): axonal damage as a consequence of functional disturbances. A new target for neuroprotection? 63
Histone deacetylases inhibitors: a new frontier for neuroprotection? 62
Blood NfL as a potential axonal damage marker in different CIPN rat models. 62
null 57
MORPHOFUNCTIONAL CHARACTERIZATION OF CIPN 53
Acute and chronic Oxaliplatin-induced peripheral neurotoxicity: two sides of the same coin 51
Satellite Glial Cells in Chemotherapy Induced Peripheral Neuropathy 49
DIFFERENT DEGREES OF MACROPHAGE INFILTRATION IN PRECLINICAL MODELS OF ANTITUBULIN AGENTS-INDUCED PERIPHERAL NEUROTOXICITY 48
CIPN and its mechanism of development 45
Insight Into Chemotherapeutic-Agents-Induced-Neuroinflammation In Rat Experimental Neuropathies 45
EXPLOITING HDAC6 SPECIFIC INHIBITORS TO REDUCE OHP-INDUCED NEUROTOXICITY 45
Dorsal Root Ganglia Neurons Morphometry Analysing Method Optimization 43
The different susceptibility to oxaliplatin neurotoxicity in mice is related to change in expression of the anion exchanger SLC4A1 40
NEUROINFLAMMATION AS A POTENTIAL TARGET FOR CIPN DIAGNOSTIC AND TREATMENT 38
Paclitaxel alters the microvascular network in the central and peripheral nervous system of rats with chemotherapy-induced painful peripheral neuropathy 37
UNVEILING THE MICROVASCULAR NETWORK ALTERATIONS IN THE CENTRAL AND PERIPHERAL NERVOUS SYSTEM OF RATS EXPOSED TO NEUROTOXIC CHEMOTHERAPY 18
Making Connections: Mesenchymal Stem Cells Manifold Ways to Interact with Neurons 16
MALDI mass spectrometry imaging for in situ analysis of DRGs: Oxaliplatin modifies the tissue proteome 7
Totale 13.131
Categoria #
all - tutte 45.285
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 45.285


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.077 0 0 0 0 0 241 265 109 138 163 135 26
2020/20212.080 77 58 265 196 180 224 223 220 175 146 123 193
2021/20221.294 104 117 107 137 118 139 56 71 51 80 103 211
2022/20232.289 217 531 299 238 208 324 57 105 138 40 63 69
2023/20241.731 59 65 61 119 197 362 307 98 101 47 57 258
2024/20251.954 262 463 436 226 389 178 0 0 0 0 0 0
Totale 13.131